Physiotherapy

NTM Symposium – October 2026   The Nontuberculous Mycobacteria (NTM) Australia Research Network is holding a symposium in Brisbane, Australia, from October 22nd to 23rd. This symposium is brought to you by leading clinicians, researchers and scientists. Over the course of this event, attendees will have the opportunity to review clinical aspects of NTM diagnosis […]

Asia Pacific Bronchiectasis & NTM Conference   The Asia Pacific Bronchiectasis Conference is being held in Tokyo from November 13 to 15, 2026. This ground breaking event marks the first conference exclusively dedicated to Bronchiectasis and non-tuberculous mycobacterial (NTM) diseases in the Asia-Pacific region. Go to this link for the key dates and registration details:

Highlights from the American Thoracic Society’s (ATS) Conference June 2 at 12:30 pm ET Join us as Professor James Chalmers reviews the Bronchiectasis, NTM and PCD highlights from the American Thoracic Society’s (ATS) Conference taking place in Orlando, FL, May 15-20. We may also have some supplemental oxygen updates from the conference. The ATS International

Bronchiectasis Toolbox clinical survey Clinician Perspectives on the Bronchiectasis Toolbox: A Survey Study — now open We are inviting healthcare professionals involved in the care of people with bronchiectasis to take part in an online survey exploring awareness, perceptions, and use of the Bronchiectasis Toolbox (www.bronchiectasis.com.au). Your insights will help us understand how web-based educational

The 1st European Workshop on Bronchiectasis and Cough in Children and Adults is being held in Italy. Date: 26th – 27th February 2026 Venue: Radisson Blu Hotel, Bergamo Italy Register here.

Indigenous bronchiectasis assessment scale – the ‘IBAS’: a proposed new tool to assess bronchiectasis severity in adult Indigenous Australians Howarth T, Sorger L, Saad HB, Ford PL, Heraganahally SS. Indigenous bronchiectasis assessment scale – the ‘IBAS’: a proposed new tool to assess bronchiectasis severity in adult Indigenous Australians. Intern Med J. 2025 Oct;55(10):1701-1711. doi: 10.1111/imj.70118.

Advancing Bronchiectasis Care in Adult Indigenous People – An Australian Rural and Remote Perspective  Heraganahally, S.S., Howarth, T., Chen, W. et al. Advancing Bronchiectasis Care in Adult Indigenous People – An Australian Rural and Remote Perspective. Curr Pulmonol Rep 14, 29 (2025). https://doi.org/10.1007/s13665-025-00395-y This review synthesizes the current literature and integrates insights from local and national experts to inform

European Respiratory Society and American Thoracic Society guidelines for the diagnosis of Primary Ciliary Dyskinesia This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved

The European Respiratory Society guidelines for the management of adult bronchiectasis describe the appropriate investigation and treatment strategies determined by a systematic review of the literature. These recommendations can be used to benchmark quality of care for people with bronchiectasis across Europe and to improve outcomes. ERS Guidelines for the management of adult bronchiectasis

Symptoms alone could guide bronchiectasis treatment A multinational study of more than 9,000 patients has found that symptoms alone can predict future exacerbations in bronchiectasis, potentially expanding treatment eligibility beyond current guideline recommendations. The research, published in The Lancet Respiratory Medicine [link here], challenges existing guidelines that limit long-term macrolide therapy to patients experiencing three or more